WallStSmart
IVVD

Invivyd Inc.

NASDAQ: IVVD · HEALTHCARE · BIOTECHNOLOGY

$1.40
+2.94% today

Updated 2026-04-30

Market cap
$412.89M
P/E ratio
P/S ratio
7.73x
EPS (TTM)
$-0.30
Dividend yield
52W range
$0 – $3
Volume
2.8M

WallStSmart proprietary scores

36
out of 100
Grade: D
Sell
Investment rating
5.7
Growth
C+
5.0
Quality
C+
2.0
Profitability
F
5.0
Valuation
C+
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →201 stocks currently score above 75

Price targets

Analyst target
$10.00
+614.29%
12-Month target
Intrinsic (DCF)
Margin of safety
0 Strong Buy3 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths
+ Revenue growth 24.50% QoQ
Risks
- Thin margins at -98.30%
- Negative free cash flow $-15.46M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$0.00$0.00$25.38M$53.43M$53.43M
Net income$-241.32M$-198.64M$-169.93M$-52.49M$-11.07M
EPS$-0.30
Free cash flow$-221.69M$-173.78M$-170.63M$-58.29M$-15.46M
Profit margin-669.42%-98.25%-98.30%

Recent insider activity

DateInsiderTypeSharesPrice
2026-02-18LEE, TIMOTHY EDWARDSale20,964$1.58
2026-02-18GREEN, JULIESale20,964$1.58
2026-02-18DUKE, WILLIAM E.Sale20,964$1.58

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
IVVD$412.89M365.72.05.05.0Hold
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$322.34B545.35.57.34.8+42.06%Buy
AZN$294.17B646.78.05.35.0+4.07%Buy

Smart narrative

Invivyd Inc. trades at $1.40. Our Smart Value Score of 36/100 indicates the stock is weak. TTM revenue stands at $53.43M. with profit margins at -98.30%.

Frequently asked questions

What is Invivyd Inc.'s stock price?
Invivyd Inc. (IVVD) trades at $1.40.
Is Invivyd Inc. overvalued?
Smart Value Score 36/100 (Grade D, Sell).
What is the price target of Invivyd Inc. (IVVD)?
The analyst target price is $10.00, representing +614.3% upside from the current price of $1.40.
What is Invivyd Inc.'s revenue?
TTM revenue is $53.43M.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio7.73x
ROE-34.00%
Beta0.74
50D MA$1.59
200D MA$1.62
Shares out0.28B
Float0.17B
Short ratio
Avg volume2.8M

Performance

1 week-8.75%
1 month+22.69%
3 months-23.96%
YTD-40.89%
1 year
3 years
5 years